Cargando…
Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity
IL-2 is the master-regulator cytokine for T cell dependent responses and is crucial for proliferation and survival of T cells. However, IL-2-based treatments remained marginal, in part due to short half-life. Thus, we aimed to extend IL-2 half-life by flanking the IL-2 core with sequences derived fr...
Autores principales: | Ottolenghi, Aner, Bolel, Priyanka, Sarkar, Rhitajit, Greenshpan, Yariv, Iraqi, Muhammed, Ghosh, Susmita, Bhattacharya, Baisali, Taylor, Zoe V., Kundu, Kiran, Radinsky, Olga, Gazit, Roi, Stepensky, David, Apte, Ron N., Voronov, Elena, Porgador, Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027413/ https://www.ncbi.nlm.nih.gov/pubmed/33828163 http://dx.doi.org/10.1038/s41598-021-87102-4 |
Ejemplares similares
-
N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune Evasion
por: Iraqi, Muhammed, et al.
Publicado: (2020) -
Synthetic promoters to induce immune-effectors into the tumor microenvironment
por: Greenshpan, Yariv, et al.
Publicado: (2021) -
Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma
por: Iraqi, Muhammed, et al.
Publicado: (2022) -
High throughput screen for the improvement of inducible promoters for tumor microenvironment cues
por: Sharabi, Omri, et al.
Publicado: (2022) -
NKp44-Derived Peptide Used in Combination Stimulates Antineoplastic Efficacy of Targeted Therapeutic Drugs
por: Iraqi, Muhammed, et al.
Publicado: (2022)